• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗生素、细胞因子与内毒素:革兰氏阴性菌败血症中复杂且不断演变的关系

Antibiotics, cytokines, and endotoxin: a complex and evolving relationship in gram-negative sepsis.

作者信息

Horn D L, Opal S M, Lomastro E

机构信息

Merck US Human Health, West Point, PA, USA.

出版信息

Scand J Infect Dis Suppl. 1996;101:9-13.

PMID:9060045
Abstract

Compelling experimental evidence now exists that antimicrobial agents induce the release of endotoxin from Gram-negative bacteria during the process of bacteriolysis. Different antimicrobial classes, particularly those which act upon the outer membrane of bacteria, vary in the amount of free endotoxin released from Gram-negative organisms. Despite this in vitro evidence, clinically important consequences of antibiotic-induced endotoxin release have yet to be consistently documented. Complexities in the host-pathogen interactions during actual infection with Gram-negative bacteria may account for the difficulties in demonstrating this phenomena in vivo. This brief review analyses these interactions and defines clinical settings where antibiotic-induced endotoxin release may prove to be clinically relevant.

摘要

目前已有令人信服的实验证据表明,抗菌剂在细菌溶解过程中会诱导革兰氏阴性菌释放内毒素。不同种类的抗菌剂,尤其是那些作用于细菌外膜的抗菌剂,从革兰氏阴性菌释放的游离内毒素量各不相同。尽管有这些体外实验证据,但抗生素诱导内毒素释放的临床重要后果尚未得到一致证实。在革兰氏阴性菌实际感染期间宿主与病原体相互作用的复杂性,可能是在体内证明这一现象存在困难的原因。本简要综述分析了这些相互作用,并确定了抗生素诱导内毒素释放可能具有临床相关性的临床情况。

相似文献

1
Antibiotics, cytokines, and endotoxin: a complex and evolving relationship in gram-negative sepsis.抗生素、细胞因子与内毒素:革兰氏阴性菌败血症中复杂且不断演变的关系
Scand J Infect Dis Suppl. 1996;101:9-13.
2
Evidence for antibiotic-mediated endotoxin release as a contributing factor to lethality in experimental gram-negative sepsis.抗生素介导的内毒素释放作为实验性革兰氏阴性菌败血症致死率的一个促成因素的证据。
Scand J Infect Dis Suppl. 1996;101:3-8.
3
Antibiotic-mediated release of endotoxin and the pathogenesis of gram-negative sepsis.抗生素介导的内毒素释放与革兰氏阴性菌败血症的发病机制。
Prog Clin Biol Res. 1998;397:199-207.
4
Clinical implications of antibiotic-induced endotoxin release in septic shock.抗生素诱导的内毒素释放对脓毒症休克的临床影响
Intensive Care Med. 2002 Jul;28(7):824-33. doi: 10.1007/s00134-002-1330-6. Epub 2002 May 30.
5
Antibiotic induced endotoxin release and clinical sepsis: a review.抗生素诱导的内毒素释放与临床脓毒症:综述
J Chemother. 2001 Nov;13 Spec No 1(1):159-72. doi: 10.1179/joc.2001.13.Supplement-2.159.
6
Antibiotic treatment in a murine model of sepsis: impact on cytokines and endotoxin release.脓毒症小鼠模型中的抗生素治疗:对细胞因子和内毒素释放的影响。
Shock. 2004 Feb;21(2):115-20. doi: 10.1097/01.shk.0000111828.07309.21.
7
The therapeutic challenge of Gram-negative sepsis: prolonging the lifespan of a scarce resource.
Clin Microbiol Infect. 2005 Nov;11 Suppl 6:18-22. doi: 10.1111/j.1469-0691.2005.01266.x.
8
Continuous administration of PBP-2- and PBP-3-specific beta-lactams causes higher cytokine responses in murine Pseudomonas aeruginosa and Escherichia coli sepsis.持续给予针对PBP-2和PBP-3的β-内酰胺类药物会在小鼠铜绿假单胞菌和大肠杆菌败血症中引发更高的细胞因子反应。
J Antimicrob Chemother. 2007 May;59(5):926-33. doi: 10.1093/jac/dkm073. Epub 2007 Mar 29.
9
Endotoxin release after antibiotic treatment and its potential pathogenetic role in coagulative disorders of patients with gram-negative sepsis.抗生素治疗后内毒素释放及其在革兰阴性菌败血症患者凝血障碍中的潜在致病作用。
J Chemother. 1991 Jan;3 Suppl 1:69-72.
10
Peptide-based treatment of sepsis.基于肽的败血症治疗。
Appl Microbiol Biotechnol. 2011 May;90(3):799-808. doi: 10.1007/s00253-011-3185-7. Epub 2011 Mar 3.

引用本文的文献

1
Multi-drug strategies are necessary to inhibit the synergistic mechanism causing tissue damage and organ failure in post infectious sequelae.多药策略对于抑制协同机制导致的感染后后遗症中的组织损伤和器官衰竭是必要的。
Inflammopharmacology. 1999;7(3):207-17. doi: 10.1007/s10787-999-0004-1.
2
Drotrecogin alfa (activated).重组人活化蛋白C(drotrecogin alfa)
Drugs. 2002;62(4):617-30; discussion 631-2. doi: 10.2165/00003495-200262040-00006.
3
Differential tumor necrosis factor alpha expression and release from peritoneal mouse macrophages in vitro in response to proliferating gram-positive versus gram-negative bacteria.
体外培养的小鼠腹腔巨噬细胞对革兰氏阳性菌和革兰氏阴性菌增殖反应时肿瘤坏死因子α的差异表达与释放
Infect Immun. 2000 Aug;68(8):4422-9. doi: 10.1128/IAI.68.8.4422-4429.2000.
4
Differential host inflammatory responses to viable versus antibiotic-killed bacteria in experimental microbial sepsis.实验性微生物败血症中宿主对活菌与抗生素灭活菌的不同炎症反应。
Infect Immun. 2000 Apr;68(4):2301-8. doi: 10.1128/IAI.68.4.2301-2308.2000.
5
Modulation of endotoxin- and enterotoxin-induced cytokine release by in vivo treatment with beta-(1,6)-branched beta-(1,3)-glucan.通过体内给予β-(1,6)-分支β-(1,3)-葡聚糖调节内毒素和肠毒素诱导的细胞因子释放。
Infect Immun. 1999 Jan;67(1):244-52. doi: 10.1128/IAI.67.1.244-252.1999.
6
Antiendotoxin strategies for the prevention and treatment of septic shock. New approaches and future directions.用于预防和治疗脓毒性休克的抗内毒素策略。新方法与未来方向。
Drugs. 1998 Apr;55(4):497-508. doi: 10.2165/00003495-199855040-00002.